Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis

J Neurol. 2021 Dec;268(12):4483-4485. doi: 10.1007/s00415-021-10599-2. Epub 2021 May 22.

¹ Department of Neurology, Evangelisches Klinikum Bethel, OWL University Hospital, Bielefeld University, Bielefeld-Bethel Campus, Bielefeld, Germany.
² Department of Transfusion Medicine, Institute for Immunology and Transfusion Medicine, University Medicine Greifswald, Greifswald, Germany.
³ Department of Neuroradiology, Evangelisches Klinikum Bethel, OWL University Hospital, Bielefeld University, Bielefeld-Bethel Campus, Bielefeld, Germany.
⁴ Department of Neurology, Evangelisches Klinikum Bethel, OWL University Hospital, Bielefeld University, Bielefeld-Bethel Campus, Bielefeld, Germany. [email protected].

No abstract available

Publication types